U.S. Physical Therapy (USPH)
What the price implies
A reverse DCF: instead of guessing a fair value, it asks what growth today's price already assumes. How it works.
At a market value of $1.3B, U.S. Physical Therapy's free cash flow of $61M (fiscal 2025) would need to grow about 6% a year for the stock to be worth today's price. That is close to what the company has delivered over the last 9 years.
Assumes a 9% discount rate and 3% growth after year 10, on free cash flow (operating cash flow minus capital spending) from U.S. Physical Therapy's SEC filings. Change any assumption, or model revenue and margins instead, in the Modeling tab, or try your own numbers in the reverse DCF calculator.
Fundamental grade
Five factors scored 1 to 9 from USPH's latest numbers, weighted into one grade. It describes the business, not whether the stock is a buy.
Key numbers
Results from SEC filings
Fiscal years, from U.S. Physical Therapy's 10-K filings. Ten years of the full income statement, balance sheet and cash flow.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $495M | $553M | $605M | $671M | $781M |
| Net income | $41M | $32M | $28M | $31M | $40M |
| Free cash flow | $68M | $50M | $73M | $66M | $61M |
| EPS (diluted) | $2.41 | $2.25 | $1.28 | $1.84 | $1.42 |
| Operating margin | 14.3% | 10.3% | 8.4% | 9.4% | 11.1% |
Where the revenue comes from
Revenue by segments, fiscal 2025. Every breakdown, year by year.
Superinvestors who own USPH
From each investor's latest 13F filing (what a 13F shows). 1 of the investors we track hold it.
| Investor | Last quarter | Value | % of portfolio | Quarter |
|---|---|---|---|---|
| Cliff Asness AQR Capital Management |
Added | $1M | 0.0% | Q2 2026 |
Insider buying
Open-market purchases by U.S. Physical Therapy's executives and directors in the last 12 months, from SEC Form 4 filings. What insider buying tells you.
| Date | Insider | Shares | Price | Value |
|---|---|---|---|---|
| Sep 11, 2026 | Peter Francis Minan Director |
5 | $79.00 | $416 |
| Jun 12, 2026 | Peter Francis Minan Director |
1 | $66.50 | $58 |
Get an alert at your buy price
Pick the price you'd be interested at. We'll email you when USPH trades at or below it.
New accounts get 7 days of Pro, price alerts included. No card needed.
In the full deep dive
Questions
What growth does U.S. Physical Therapy's stock price imply?
At a market value of $1.3B, U.S. Physical Therapy would need its free cash flow to grow about 6% a year for 10 years (discounted at 9%, 3% growth after that) to be worth today's price. Over the last 9 years its free cash flow grew 4% a year.
Are U.S. Physical Therapy insiders buying the stock?
2 open-market insider purchases of USPH in the last 12 months, from SEC Form 4 filings.
Which superinvestors own U.S. Physical Therapy?
1 of the superinvestors Investingly tracks hold USPH in their latest 13F, including Cliff Asness.
Companies like U.S. Physical Therapy
All Healthcare stocks · Medical Care Facilities stocks · Stock lists
Prices and ratios as of Oct 11, 2026; statements from SEC filings. Information only, not investment advice. Superinvestor holdings come from 13F filings, which are filed up to 45 days after each quarter ends.